Tango Therapeutics Inc.

NASDAQ: TNGX · Real-Time Price · USD
1.86
-0.00 (-0.27%)
At close: May 23, 2025, 3:59 PM
1.90
1.88%
After-hours: May 23, 2025, 05:49 PM EDT

Tango Therapeutics Revenue Breakdown

Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Collaboration Revenue Revenue 29.97M 31.53M 24.86M 26.04M
Collaboration Revenue Revenue Growth -4.94% +26.82% -4.54% n/a
License Revenue Revenue 12.1M 5M n/a 11M
License Revenue Revenue Growth +142.00% n/a n/a n/a

Operating Expense Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Selling, General, and Administrative Revenue 11.48M 11.09M 11.22M 10.14M 10.04M 9.11M 9.21M 9.17M 8.01M 7.89M 8.1M 7.23M 6.81M 6.07M 4.43M 3.63M 3.47M 3.02M 2.52M 2.38M 1.95M
Selling, General, and Administrative Revenue Growth +3.52% -1.18% +10.66% +1.05% +10.23% -1.13% +0.38% +14.49% +1.60% -2.62% +11.99% +6.24% +12.22% +36.84% +22.12% +4.70% +14.95% +19.78% +5.89% +21.76% n/a
Research and Development Revenue 36.44M 33.94M 33.26M 38.65M 38.06M 31.34M 27.15M 28.67M 28.04M 29.09M 28.74M 23.74M 24.33M 21.63M 21.92M 19.08M 15M 15.06M 12.98M 11.13M 10.82M
Research and Development Revenue Growth +7.38% +2.03% -13.95% +1.55% +21.46% +15.43% -5.31% +2.25% -3.62% +1.21% +21.07% -2.42% +12.46% -1.32% +14.91% +27.19% -0.42% +16.07% +16.61% +2.84% n/a